MedTrace Logo

Bone Mineral Density Changes Among Clinical Subtypes of Parkinson's Disease

NCT03806517 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 75

Last updated 2019-02-12

No results posted yet for this study

Summary

The bone loss in Parkinson's disease (PD) emerges as a non-motor symptom with motor and non-motor outcomes, such as fracture and musculoskeletal pain. Bone mineral density (BMD) is decreasing in patients with PD when compared to sex and age-matched healthy controls. The changes in BMD according to clinical subtypes of PD is unknown. The investigators are planning to compare the BMD status between the tremor dominant and postural instability and gait difficulty type of PD.

Conditions

  • Parkinson Disease
  • Bone Loss

Sponsors & Collaborators

  • T.C. ORDU ÜNİVERSİTESİ

    lead OTHER

Principal Investigators

  • Sevim ACARÖZ CANDAN · T.C. ORDU ÜNİVERSİTESİ

Eligibility

Min Age
40 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-02-10
Primary Completion
2019-02-25
Completion
2019-02-28

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03806517 on ClinicalTrials.gov